Vendor, Frederick, MD, part of Leidos Holdings, Inc.
Leidos Biomedical Research Inc.
UEI HV8BH9BPG8Y9, CAGE 3LYK6
53 awards and $104,761,901 obligated between June 17, 2026 and September 11, 2026, 89% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $107,909,304 |
| Facilities Support ServicesNAICS 561210 | -$3,147,403 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 47 |
| Not Competed | 6 |
| Delivery Order | 52 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025F00016Delivery Order, June 30, 2026, Full and Open Competition | NIH NCINational Institutes of Health | NCI Operational Task Order, Fy26-Fy27NAICS 541715, PSC AN12 | $158,363,868 |
| 75N91025F00014Delivery Order, July 8, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Niaid VRC FY26-27 Operational Task OrderNAICS 541715, PSC AN12 | $44,883,384 |
| 75N91019F00139Delivery Order, September 3, 2026, Full and Open Competition | NIH NCINational Institutes of Health | MD NetNAICS 541715, PSC AN12 | $17,907,031 |
| 75N91021F00017Delivery Order, August 21, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Elaboration and Use of Syngenic Pre-Clinical Models for Cancer Drug DevelopmentNAICS 541715, PSC AN12 | $11,687,558 |
| 75N91021F00013Delivery Order, August 28, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Childhood Cancer Research and CCDSFNAICS 541715, PSC AN12 | $11,231,388 |
| 75N91025F00012Delivery Order, July 2, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Niaid DCR FY26-27 Operational Task OrderNAICS 541715, PSC AN12 | $10,193,922 |
| 75N91025F00008Delivery Order, July 2, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY25 To-C Refurbish ElevatorsNAICS 541715, PSC AN12 | $5,836,607 |
| 75N91020F00022Delivery Order, July 10, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Niaid Research Data Ecosystem Framework (Nidef)NAICS 541715, PSC AN12 | $5,253,331 |
| 75N91024F00021Delivery Order, July 22, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Niaid VRC Pre-Clinical AssessmentNAICS 541715, PSC AN12 | $3,976,008 |
| 75N91020F00021Delivery Order, June 17, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Childhood Cancer Data Initiative: Clinical Trial Specimen Molecular Characterization (Ctsmc) ProgramNAICS 541715, PSC AN12 | $3,749,767 |
| 75N91025F00024Delivery Order, August 3, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Develop, Qualify Immunological Assays, and Provide Clinical Sample Testing for AAV-BASED Gene Therapy Clinical CandidatesNAICS 541715, PSC AN12 | $2,047,008 |
| 75N91026F00028Delivery Order, September 3, 2026, Full and Open Competition | NIH NCINational Institutes of Health | 126797 Campus Replace BSCSNAICS 541715, PSC AN12 | $1,912,753 |
| 75N91026F00006Delivery Order, July 10, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY26 126816_B539 _B536 W End Fire AlarmNAICS 541715, PSC AN12 | $1,756,369 |
| 75N91026F00023Delivery Order, August 26, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FFRDC Drug Product Formulation, Manufacture, and Stability Studies of Bethanechol Chloride for Phase I Clinical TrialsNAICS 541715, PSC AN12 | $1,644,574 |
| 75N91026F00030Delivery Order, August 27, 2026, Full and Open Competition | NIH NCINational Institutes of Health | 126869 B539 & 560 - Roof ReplacementsNAICS 541715, PSC AN12 | $1,511,990 |
| 75N91025F00013Delivery Order, July 31, 2026, Full and Open Competition | NIH NCINational Institutes of Health | The Niaid Dir FY26-27 Operational Task OrderNAICS 541715, PSC AN12 | $1,412,167 |
| 75N91026F00024Delivery Order, September 10, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Implementation and Characterization of Ipsc-Derived Cell and Organoid Models for Integration Into New Approach Methodologies (Nams)NAICS 541715, PSC AN12 | $1,323,885 |
| 75N91026F00021Delivery Order, September 8, 2026, Full and Open Competition | NIH NCINational Institutes of Health | 126889 B571 Replace Chiller #3NAICS 541715, PSC AN12 | $1,291,828 |
| 75N91026F00017Delivery Order, August 28, 2026, Full and Open Competition | NIH NCINational Institutes of Health | 126729 Room 524 D, E, FNAICS 541715, PSC AN12 | $1,102,374 |
| 75N91026F00011Delivery Order, August 28, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY26 125346 - B539 Storm Drain ReplacementNAICS 541715, PSC AN12 | $1,064,983 |
| 75N91026F00025Delivery Order, August 24, 2026, Full and Open Competition | NIH NCINational Institutes of Health | 126864 Multi Building Dry Chem Fire Suppression SystemNAICS 541715, PSC AN12 | $880,989 |
| 75N91026F00031Delivery Order, September 3, 2026, Full and Open Competition | NIH NCINational Institutes of Health | 126297 Campus Evaluate & Replace Deficient Alternating Tread and Ship StairsNAICS 541715, PSC AN12 | $806,968 |
| 75N91025F00005Delivery Order, August 19, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY26 FFRDC LeasesNAICS 541715, PSC AN12 | $737,080 |
| 75N91025F00021Delivery Order, July 20, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Manufacturing CGMP Grade HydroxycobalamineNAICS 541715, PSC AN12 | $668,886 |
| 75N91026F00018Delivery Order, July 30, 2026, Full and Open Competition | NIH NCINational Institutes of Health | 126827 Building 1023 Rooms 8 and 9 BSC ReplacementNAICS 541715, PSC AN12 | $652,353 |
| 75N91026F00022Delivery Order, August 24, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FFRDC Pth-1a Drug Product for Pediatric DosingNAICS 541715, PSC AN12 | $559,073 |
| 75N91025F00011Delivery Order, July 24, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY25 Facilities to G Construction of BMP Structures for Mde Storm-Water ComplianceNAICS 541715, PSC AN12 | $462,046 |
| 75N91023F00023Delivery Order, July 10, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Characterization of Nanoparticles Encapsulating Oligonucleotides for Targeting Endocytosis in Nociceptors for the Treatment of Neuropathic PNAICS 541715, PSC AN12 | $383,255 |
| 75N91025F00020Delivery Order, July 1, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Producing Usher III Retinal Organoids from Patient Cells to Measure the Effect of Drug CandidateNAICS 541715, PSC AN12 | $286,678 |
| 75N91020F00015Delivery Order, July 2, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Data Systems Update, Data Integration, and Computational Applications to Support Drug Discovery and Therapeutics DevelopmentNAICS 541715, PSC AN12 | $250,000 |
| 75N91025F00004Delivery Order, August 12, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY25 Facilities Task Order a - Replace Wood Street Steam & Condensate Piping Mod 003 - Funds IncreaseNAICS 541715, PSC AN12 | $145,045 |
| 75N91021F00016Delivery Order, June 25, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Development of Canine Immunotherapy Targeted AgentsNAICS 541715, PSC AN12 | $109,311 |
| HHSN26100019Delivery Order, August 25, 2026, Not Competed | NIH NCINational Institutes of Health | Research, Development, Production and Support for Clinical Trials Broadly Neutralizing Monoclonal Antibodies (Bnmabs)NAICS 561210, PSC M1HA | $49,826 |
| 75N91018F00080Delivery Order, September 11, 2026, Not Competed | NIH NCINational Institutes of Health | The Purpose of This Modification Is to Is to Extend the Period of Performance of the Subject Task Order. Articles F.1 & G.3.C Has Been RevisNAICS 561210, PSC M1HA | $0 |
| 75N91021F00019Delivery Order, August 19, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Request for Extension of Period of Performance. Mod 0012NAICS 541715, PSC M1HA | $0 |
| 75N91022F00013Delivery Order, July 22, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Niaid-Vrc-Mrna Vaccine Capability EstablishmentNAICS 541715, PSC AN12 | $0 |
| 75N91023F00008Delivery Order, July 22, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Niaid Dmid Next Generation Covid Vaccine TrialNAICS 541715, PSC AN12 | $0 |
| 75N91023F00009Delivery Order, July 1, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Insilico and EX-VIVO Immunogenicity Analysis of Ncats Gene Therapy TestNAICS 541715, PSC AN12 | $0 |
| 75N91025F00009Delivery Order, August 20, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY25 Facilities to E - 126663 B539 Misc Safety UpgradesNAICS 541715, PSC AN12 | $0 |
| 75N91025F00017Delivery Order, August 24, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Characterization of MpoxNAICS 541715, PSC AN12 | $0 |
| 75N91020F00006Delivery Order, June 18, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY26 Udo InitiativeNAICS 541715, PSC AN12 | -$361 |
| 75N91018F00072Delivery Order, June 18, 2026, Not Competed | NIH NCINational Institutes of Health | FY26 Udo Initiative Refractory Cancers Biospecimen Acquisition and Genomic CharacterizationNAICS 561210, PSC M1HA | -$1,106 |
| 75N91018F00066Delivery Order, June 18, 2026, Not Competed | NIH NCINational Institutes of Health | FY26 Udo InitiativeNAICS 561210, PSC M1HA | -$3,163 |
| 75N91020F00003Delivery Order, June 18, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY26 Udo Initiative - NCI Operational Task Order FY20 - FY23NAICS 541715, PSC M1HA | -$10,806 |
| 75N91025F00007Delivery Order, June 26, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY25 To-BNAICS 541715, PSC AN12 | -$17,849 |
| HHSN261200800001EDefinitive Contract, July 17, 2026, Not Competed, 1 offers | NIH NCINational Institutes of Health | 2026 Udo Sprint Initiative - Deobligation of Unused FundingNAICS 561210, PSC M181 | -$1,340,234 |
| 75N91019F00140Delivery Order, September 8, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Neuresta Drug Substance ManufacturingNAICS 541715, PSC AN12 | -$1,654,198 |
| HHSN26100041Delivery Order, June 18, 2026, Not Competed | NIH NCINational Institutes of Health | FY26 Udo Initiative - Human Tumor Atlas Pilot ProgramNAICS 561210, PSC M1HA | -$1,852,726 |
| 75N91019F00130Delivery Order, June 22, 2026, Full and Open Competition | NIH NCINational Institutes of Health | FY26 Udo InitiativeNAICS 541715, PSC M1HA | -$2,690,270 |
| 75N91022F00020Delivery Order, August 4, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Eoi:: Implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOINAICS 541715, PSC AN12 | -$3,154,268 |
| 75N91020F00014Delivery Order, August 21, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Eoi:: Implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOINAICS 541715, PSC AN12 | -$40,507,782 |
| 75N91021F00001Delivery Order, September 3, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Eoi:: Implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::center for Serological ScNAICS 541715, PSC AN12 | -$63,681,191 |
| 75N91020F00039Delivery Order, September 9, 2026, Full and Open Competition | NIH NCINational Institutes of Health | Niaid Covid-19 Activ3NAICS 541715, PSC AN12 | -$74,466,450 |
- Places of performance
- Maryland
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied ResearchM181 Operate Govt Owned BuildingsM1HA Operation Of Government-Owned Contractor-Operated (Goco) R&D Facilities
- Transactions
- 64 across 53 awards